SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Tomorrow.io raises $175 million at over $1 billion valuation to build AI-driven weather satellite network

Cyber startup Orion raises $32 million Series A backed by IBM for AI-driven data-leak prevention

Full list of Israeli startup M&As in 2026

Medtronic to acquire Israeli AI cardiology firm CathWorks for $585 million, deal could reach $1 billion

Buzz

Most popular

Daily

Weekly

1

Chinese fund: “The Chinese government has imposed a ban on any new investment in Israel”

2

Israeli defense firms target Asia as Singapore Airshow opens amid regional arms race

3

Medtronic to acquire Israeli AI cardiology firm CathWorks for $585 million, deal could reach $1 billion

4

After $400M cyber exit, ex-IntSights CEO raises $11M to build AI app for personalized sports highlights

5

Why Apple paid billions for a company with no revenue

Rimsa

3 stories about Rimsa

Israeli court documents reveal worrying details on Teva’s decision to acquire Mexico’s Rimsa

08.06.20|Sophie Shulman

Classified documents show that Teva's board of directors didn't even dedicate a full meeting to the acquisition

מטה חברת טבע תרופות

Derivative Suit Sheds Light on Teva’s Disastrous Rimsa Acquisition

28.05.19|Hezi Sternlicht

Teva acquired Mexican drugmaker Rimsa in 2016, but an anonymous email sent a week after the deal’s completion led Teva to launch an internal investigation—and sue the sellers for fraud

Teva and Rimsa Settle Contested $2.3-Billion Acquisition Deal Out of Court

10.04.18|Dror Reich

Teva acquired the Mexican plant in 2016 but shut it down immediately, citing discrepancies between Rimsa's regulatory filing and the actual assets, and filed a suit against the former owners